News That Matters

Understanding ImmunityBio: A Breakthrough in Cancer Treatment

Cancer is a leading cause of death worldwide, with over 10 million deaths every year. Despite significant progress in cancer treatment, there is still a need for more effective therapies. ImmunityBio is a biotechnology company at the forefront of developing innovative cancer treatments that leverage the power of the immune system. By boosting the immune system’s ability to recognize and attack cancer cells, ImmunityBio’s therapies have the potential to transform cancer treatment.

How ImmunityBio Works

Targeting the Tumor Microenvironment

ImmunityBio’s treatments work by targeting the tumor microenvironment, which is the network of cells and molecules that surrounds the tumor. This microenvironment provides the tumor with nutrients, oxygen, and a shield against the immune system. ImmunityBio’s approach is to break down this shield by targeting specific molecules that are overexpressed in the tumor microenvironment.

Activating T Cells

ImmunityBio’s therapies also activate T cells, which are a type of immune cell that plays a key role in fighting cancer. By boosting the activity of T cells, ImmunityBio’s treatments can help to overcome the immune system’s tolerance of the tumor and increase the chances of an effective immune response.

ImmunityBio’s Therapies


N-803 is a cytokine therapy that stimulates the immune system’s response to cancer cells. It works by activating NK and T cells, which are essential components of the immune system’s antitumor response. N-803 has shown promising results in clinical trials, including complete responses in patients with metastatic melanoma and kidney cancer.

ACTR Therapy

ACTR therapy is a type of cell therapy that involves genetically engineering T cells to express a protein called the “anti-CD16 receptor.” This receptor enhances the ability of T cells to recognize and attack cancer cells, leading to a more effective immune response. ACTR therapy has shown promising results in preclinical studies and is currently in clinical trials.


What types of cancer can ImmunityBio’s therapies treat?

ImmunityBio’s therapies have shown promise in a variety of cancer types, including melanoma, kidney cancer, and pancreatic cancer. The company is also exploring the potential of its therapies in other types of cancer.

Are ImmunityBio’s therapies safe?

Like all cancer therapies, ImmunityBio’s treatments can have side effects. However, the company’s therapies have shown a favorable safety profile in clinical trials.


ImmunityBio is a pioneering biotechnology company that is pushing the boundaries of cancer treatment. By developing innovative therapies that harness the power of the immune system, ImmunityBio has the potential to transform cancer treatment and improve the lives of millions of patients worldwide. With promising results in clinical trials, the future of ImmunityBio’s therapies looks bright, and we can expect to see more breakthroughs in cancer treatment in the coming years.